Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.24
+0.07 (0.33%)
Aug 26, 2026, 4:00 PM EDT - Market closed

Innoviva Revenue

Innoviva had revenue of $119.59M in the quarter ending June 30, 2026, with 19.25% growth. This brings the company's revenue in the last twelve months to $440.00M, up 18.84% year-over-year. In the year 2025, Innoviva had annual revenue of $411.33M with 14.67% growth.

Revenue (ttm)
$440.00M
Revenue Growth
+18.84%
P/S Ratio
3.49
Revenue / Employee
$2,767,283
Employees
159
Market Cap
1.53B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025411.33M52.62M14.67%
Dec 31, 2024358.71M48.25M15.54%
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019261.02M12.00K-
Dec 31, 2018261.00M43.79M20.16%
Dec 31, 2017217.22M83.65M62.63%
Dec 31, 2016133.57M79.62M147.58%
Dec 31, 201553.95M45.52M539.74%
Dec 31, 20148.43M3.90M86.08%
Dec 31, 20134.53M-1.08M-19.26%
Dec 31, 20125.61M-18.90M-77.10%
Dec 31, 201124.51M289.00K1.19%
Dec 31, 201024.22M-151.00K-0.62%
Dec 31, 200924.37M1.28M5.53%
Dec 31, 200823.10M1.09M4.97%
Dec 31, 200722.00M2.42M12.33%
Dec 31, 200619.59M7.53M62.49%
Dec 31, 200512.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novavax413.80M
Apnimed120.15M
Ascentage Pharma Group International94.61M
Aktis Oncology10.06M
SL Science Holding3.27M
Revenue Rankings